October 16, 2021 01:14 (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Kashmir: Two terrorists behind targetted killings of civilian, cop shot dead | US to reopen land and air borders to fully vaccinated foreign visitors from Nov 8 | Navjot Sidhu meets Rahul Gandhi amid Punjab Congress turmoil | Army officer, jawan critically injured in counter terror op in J&K's poonch district | 'Will follow whatever Gandhis decide:' Navjot Sidhu after meeting senior Cong leaders amid Punjab crisis

Vaccine antibody levels start to wane at around 2-3 months: Study

London: Total antibody levels appear to start declining from as early as six weeks after complete vaccination and can reduce by more than 50% over 10 weeks, according to new data from UCL’s Virus Watch study.

COVID-19 antibodies persist at least nine months after infection: Study

London: Testing of an entire Italian town shows antibody levels remain high nine months after SARS-CoV-2 infection, whether symptomatic or asymptomatic.

Study finds COVID-19 virus triggers antibodies from previous coronavirus infections

New York: The results of a study led by Northern Arizona University and the Translational Genomics Research Institute (TGen), an affiliate of City of Hope, suggest the immune systems of people infected with COVID-19 may rely on antibodies created during infections from earlier coronaviruses to help fight the disease.

Long-term symptoms of COVID-19 ‘really concerning’, says WHO chief

New York: With some COVID-19 patients reporting long-term symptoms, including damage to major organs, the World Health Organization (WHO) urged Governments to ensure they receive necessary care.

Most people mount a strong antibody response to SARS-CoV-2 that does not decline rapidly: Study

The vast majority of individuals infected with mild-to-moderate COVID 19 mount a robust antibody response that is relatively stable for at least five months, according to research conducted at the Icahn School of Medicine at Mount Sinai and published October 28, in the journal Science. 

Coronavirus antibody prevalence falling in England, finds REACT study

London: Tests on more than 365,000 people in England have shown that the antibody response to the virus that causes COVID-19 wanes over time.

Study shows SARS-CoV-2 antibodies provide lasting immunity

Arizona: One of the most significant questions about the novel coronavirus is whether people who are infected are immune from reinfection and, if so, for how long.